DE3031710C2 - Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen. - Google Patents

Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.

Info

Publication number
DE3031710C2
DE3031710C2 DE3031710A DE3031710A DE3031710C2 DE 3031710 C2 DE3031710 C2 DE 3031710C2 DE 3031710 A DE3031710 A DE 3031710A DE 3031710 A DE3031710 A DE 3031710A DE 3031710 C2 DE3031710 C2 DE 3031710C2
Authority
DE
Germany
Prior art keywords
salts
catechin
production
pharmaceutical preparations
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3031710A
Other languages
English (en)
Other versions
DE3031710A1 (de
Inventor
Paul J. Grez-Doiceau Be Niebes
Adraz B. Bruessel/Bruxelles Be Vincze
Joseph Dion-Le-Val Be Roba
Georges Bruessel/Bruxelles Be Lambelin
Daniel M. Taviers Be Matagne
Etienne P. Hanon
Michel R. Bruessel/Bruxelles Be Franz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of DE3031710A1 publication Critical patent/DE3031710A1/de
Application granted granted Critical
Publication of DE3031710C2 publication Critical patent/DE3031710C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DE3031710A 1979-08-30 1980-08-22 Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen. Expired DE3031710C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/071,076 US4285964A (en) 1979-08-30 1979-08-30 Salts of (+)-catechine, their preparation and use, and compositions containing these salts

Publications (2)

Publication Number Publication Date
DE3031710A1 DE3031710A1 (de) 1981-03-12
DE3031710C2 true DE3031710C2 (de) 1987-03-12

Family

ID=22099096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3031710A Expired DE3031710C2 (de) 1979-08-30 1980-08-22 Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.

Country Status (18)

Country Link
US (1) US4285964A (de)
JP (2) JPS5923313B2 (de)
AT (1) AT372381B (de)
BE (1) BE884743A (de)
CA (1) CA1172259A (de)
CH (1) CH646412A5 (de)
DE (1) DE3031710C2 (de)
DK (1) DK153948C (de)
ES (1) ES494668A0 (de)
FI (1) FI72724C (de)
FR (1) FR2464262A1 (de)
GB (1) GB2057437B (de)
GR (1) GR69849B (de)
IE (1) IE50231B1 (de)
IT (1) IT1193979B (de)
NL (1) NL183080C (de)
NO (1) NO156010C (de)
SE (1) SE448455B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507314A (en) * 1983-07-20 1985-03-26 Midit, Societe Fiduciaire Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections
JPH0415053Y2 (de) * 1985-04-19 1992-04-06
EP0263132A4 (de) * 1986-04-07 1988-11-16 Clemetson Ab Charles Mit catechin beschichtete ascorbinsäure und verfahren.
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH0662408B2 (ja) * 1987-10-01 1994-08-17 太陽化学株式会社 抗う蝕及び抗歯周病組成物
JPH0672091B2 (ja) * 1988-04-13 1994-09-14 太陽化学株式会社 抗う蝕組成物
US5090785A (en) * 1990-07-31 1992-02-25 Stamp John R Multi-compartment container
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
GB2306321A (en) * 1995-10-24 1997-05-07 Anne Child The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders
GB9700912D0 (en) 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US7252834B2 (en) 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
JP2008540643A (ja) * 2005-05-17 2008-11-20 三井農林株式会社 皮膚の光老化を軽減するための組成物および方法
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
WO2012158944A1 (en) 2011-05-18 2012-11-22 Vatrix Medical, Inc. Coated balloons for blood vessel stabilization
BE1023772B9 (fr) * 2013-05-17 2017-08-02 Valore Composition a base d'un complexe de (+)-catechine et d'acide amine pour le traitement et la prevention du cancer
BE1022579A9 (fr) * 2014-11-10 2016-10-06 Valore Composition antimétastatique comprenant au moins un composé de type flavanol
TWI761672B (zh) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
US10617705B1 (en) 2019-01-24 2020-04-14 Alps Pharmaceutical Ind. Co., Ltd. Isoquercitrin compositions
US10918654B1 (en) 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270003A (en) * 1964-08-07 1966-08-30 Rayonier Inc Iron complexed sulfonated polyflavonoids and their preparation
FR2128207B1 (de) * 1971-03-11 1974-08-02 Zyma Sa
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01

Also Published As

Publication number Publication date
GR69849B (de) 1982-07-19
ATA432080A (de) 1983-02-15
DK358980A (da) 1981-03-01
ES8106513A1 (es) 1981-08-16
CA1172259A (en) 1984-08-07
NL183080C (nl) 1988-07-18
DK153948C (da) 1989-02-13
BE884743A (fr) 1980-12-01
ES494668A0 (es) 1981-08-16
FI72724B (fi) 1987-03-31
NO156010C (no) 1987-07-08
FR2464262A1 (fr) 1981-03-06
NO156010B (no) 1987-03-30
IT1193979B (it) 1988-08-31
US4285964A (en) 1981-08-25
SE8005890L (sv) 1981-03-01
JPS5946947B2 (ja) 1984-11-15
IE801823L (en) 1981-02-28
JPS59144779A (ja) 1984-08-18
FI802652A (fi) 1981-03-01
NO802563L (no) 1981-03-02
NL8004873A (nl) 1981-03-03
GB2057437B (en) 1984-08-30
IT8024310A0 (it) 1980-08-27
FR2464262B1 (de) 1983-07-08
DE3031710A1 (de) 1981-03-12
CH646412A5 (fr) 1984-11-30
IE50231B1 (en) 1986-03-05
JPS5655386A (en) 1981-05-15
AT372381B (de) 1983-09-26
GB2057437A (en) 1981-04-01
DK153948B (da) 1988-09-26
JPS5923313B2 (ja) 1984-06-01
FI72724C (fi) 1987-07-10
SE448455B (sv) 1987-02-23

Similar Documents

Publication Publication Date Title
DE3031710C2 (de) Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3765270D1 (de) N-alpha-substituierte derivate von n-alpha-arylsulfonylaminoacyl-p-amidinophenylalaninamiden, deren herstellung, deren verwendung als arzneimittel und deren zwischenverbindungen.
DE10199027I2 (de) Fluorcytidinderivate deren Herstellung und Arzneimittel die diese Derivate enthalten
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
ATE921T1 (de) Saeureadditionssalze von 2-beta, 16-beta-bis-piperidino-an drostan-16-beta-monoquaternaeren ammoniumderivaten und diese enthaltende pharmazeutische zusammensetzungen.
ATE27451T1 (de) Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3675197D1 (de) Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
ATE5188T1 (de) Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DK197689A (da) Pyridazinderivater
DE3484355D1 (de) Gefaerbte wasserfreie mittel fuer kosmetische, medizinische und aehnliche zwecke, sowie deren herstellung.
ATE3422T1 (de) Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
ATE8460T1 (de) Pharmazeutische praeparate und deren herstellung.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
DE3766418D1 (de) Substituierte benzimidazolylthiomethylbenzothiazol-derivate und deren salze, verfahren zu deren herstellung, deren medizinische anwendung und diese enthaltende zusammenstellungen.
ATE2520T1 (de) Dihydronicotinsaeurederivate und deren herstellung sowie verwendung.
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
ATE31313T1 (de) 13alpha-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE45160T1 (de) Sesquiterpen-lactone, diese enthaltende auszuege, ihre herstellung und pharmazeutische verwendung.
ATE2673T1 (de) Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: CONTINENTAL PHARMA INC., BRUESSEL/BRUXELLES, BE

8128 New person/name/address of the agent

Representative=s name: KOHLER, R., DIPL.-PHYS. SCHWINDLING, H., DIPL.-PHY

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee